353 related articles for article (PubMed ID: 35058924)
1. Recent Advances of Acute Kidney Injury in Hematopoietic Cell Transplantation.
Miyata M; Ichikawa K; Matsuki E; Watanabe M; Peltier D; Toubai T
Front Immunol; 2021; 12():779881. PubMed ID: 35058924
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic T cells cause acute renal injury after hematopoietic cell transplantation.
Miyata M; Matsuki E; Ichikawa K; Takehara T; Hosokawa Y; Sekiguchi E; Peltier D; Reddy P; Ishizawa K; Watanabe M; Toubai T
Blood Adv; 2023 Nov; 7(22):6936-6948. PubMed ID: 37748044
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome.
Zhang XH; Liu X; Wang QM; He Y; Zhu XL; Zhang JM; Han W; Chen H; Chen YH; Wang FR; Wang JZ; Zhang YY; Mo XD; Chen Y; Wang Y; Fu HX; Chang YJ; Xu LP; Liu KY; Huang XJ
Eur J Haematol; 2018 Feb; 100(2):171-181. PubMed ID: 29114931
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxis.
Shayani S; Palmer J; Stiller T; Liu X; Thomas SH; Khuu T; Parker PM; Khaled SK; Forman SJ; Nakamura R
Biol Blood Marrow Transplant; 2013 Feb; 19(2):298-304. PubMed ID: 23078784
[TBL] [Abstract][Full Text] [Related]
5. Defibrotide inhibits donor leucocyte-endothelial interactions and protects against acute graft-versus-host disease.
García-Bernal D; Palomo M; Martínez CM; Millán-Rivero JE; García-Guillén AI; Blanquer M; Díaz-Ricart M; Sackstein R; Carreras E; Moraleda JM
J Cell Mol Med; 2020 Jul; 24(14):8031-8044. PubMed ID: 32519822
[TBL] [Abstract][Full Text] [Related]
6. Acute Kidney Injury in Pediatric Patients Receiving Allogeneic Hematopoietic Cell Transplantation: Incidence, Risk Factors, and Outcomes.
Koh KN; Sunkara A; Kang G; Sooter A; Mulrooney DA; Triplett B; Onder AM; Bissler J; Cunningham LC
Biol Blood Marrow Transplant; 2018 Apr; 24(4):758-764. PubMed ID: 29196074
[TBL] [Abstract][Full Text] [Related]
7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
8. High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease.
Kraft S; Bollinger N; Bodenmann B; Heim D; Bucher C; Lengerke C; Kleber M; Tsakiris DA; Passweg J; Tzankov A; Medinger M
Bone Marrow Transplant; 2019 Apr; 54(4):540-548. PubMed ID: 30108323
[TBL] [Abstract][Full Text] [Related]
9. T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor.
Jiang H; Fu D; Bidgoli A; Paczesny S
Front Immunol; 2021; 12():761448. PubMed ID: 34675938
[TBL] [Abstract][Full Text] [Related]
10. Role of cytokines in the pathophysiology of acute graft-versus-host disease (GVHD): are serum/plasma cytokines potential biomarkers for diagnosis of acute GVHD following allogeneic hematopoietic cell transplantation (Allo-HCT)?
Toubai T; Tanaka J; Paczesny S; Shono Y; Reddy P; Imamura M
Curr Stem Cell Res Ther; 2012 May; 7(3):229-39. PubMed ID: 22023620
[TBL] [Abstract][Full Text] [Related]
11. Acute Kidney Injury and CKD Associated with Hematopoietic Stem Cell Transplantation.
Renaghan AD; Jaimes EA; Malyszko J; Perazella MA; Sprangers B; Rosner MH
Clin J Am Soc Nephrol; 2020 Feb; 15(2):289-297. PubMed ID: 31836598
[TBL] [Abstract][Full Text] [Related]
12. Impact of donor and recipient characteristics on graft-versus-host disease and survival in HLA-matched sibling hematopoietic stem cell transplantation.
Zhang H
Transfus Apher Sci; 2020 Jun; 59(3):102743. PubMed ID: 32139282
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation.
Rosenbeck LL; Kiel PJ; Kalsekar I; Vargo C; Baute J; Sullivan CK; Wood L; Abdelqader S; Schwartz J; Srivastava S; Abonour R; Robertson MJ; Nelson RP; Cornetta K; Fausel CA; Farag SS
Biol Blood Marrow Transplant; 2011 Jun; 17(6):916-22. PubMed ID: 20932925
[TBL] [Abstract][Full Text] [Related]
14. Impact of donor and recipient Epstein-Barr Virus serostatus on outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis.
Kołodziejczak M; Gil L; de la Camara R; Styczyński J;
Ann Hematol; 2021 Mar; 100(3):763-777. PubMed ID: 33491135
[TBL] [Abstract][Full Text] [Related]
15. A T-Cell Surface Marker Panel Predicts Murine Acute Graft-Versus-Host Disease.
Bäuerlein CA; Qureischi M; Mokhtari Z; Tabares P; Brede C; Jordán Garrote AL; Riedel SS; Chopra M; Reu S; Mottok A; Arellano-Viera E; Graf C; Kurzwart M; Schmiedgen K; Einsele H; Wölfl M; Schlegel PG; Beilhack A
Front Immunol; 2020; 11():593321. PubMed ID: 33584657
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation.
Sheng L; Mu Q; Wu X; Yang S; Zhu H; Wang J; Lai Y; Wu H; Sun Y; Hu Y; Fu H; Wang Y; Xu K; Sun Y; Zhang Y; Zhang P; Zhou M; Lai B; Xu Z; Gao M; Zhang Y; Ouyang G
Front Immunol; 2020; 11():1534. PubMed ID: 32849519
[No Abstract] [Full Text] [Related]
17. Acute Kidney Injury in the Modern Era of Allogeneic Hematopoietic Stem Cell Transplantation.
Abramson MH; Gutgarts V; Zheng J; Maloy MA; Ruiz JD; Scordo M; Jaimes EA; Sathick IJ
Clin J Am Soc Nephrol; 2021 Sep; 16(9):1318-1327. PubMed ID: 34135023
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT).
Efebera YA; Geyer S; Andritsos L; Vasu S; Jaglowski S; Bingman A; Blum W; Klisovic R; Hofmeister CC; Benson DM; Penza S; Elder P; Cortright K; Kitzler R; Coombes K; O'Donnell L; Daneault B; Bradbury H; Zhang J; Chen X; Garman S; Ranganathan P; Yu X; Hofstetter J; Yu J; Garzon R; Scrape SR; Lozanski G; Devine SM
Biol Blood Marrow Transplant; 2016 Jan; 22(1):71-9. PubMed ID: 26256940
[TBL] [Abstract][Full Text] [Related]
19. Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States.
Hosing C; Nash R; McSweeney P; Mineishi S; Seibold J; Griffith LM; Shulman H; Goldmuntz E; Mayes M; Parikh CR; Crofford L; Keyes-Elstein L; Furst D; Steen V; Sullivan KM
Biol Blood Marrow Transplant; 2011 May; 17(5):674-81. PubMed ID: 20708086
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of the RIFLE criteria for acute kidney injury after myeloablative allogeneic haematopoietic stem cell transplantation.
Bao YS; Xie RJ; Wang M; Feng SZ; Han MZ
Swiss Med Wkly; 2011; 141():w13225. PubMed ID: 21769755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]